Oral Abstract Session:
126. Healthcare Epidemiology: The Poop Pager and Other Novel Perspectives on C. difficile in the Healthcare Setting
Friday, October 5, 2018: 10:30 AM-11:45 AM
Room: S 156

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID


Moderators:  David Aronoff, MD, FIDSA, Vanderbilt University School of Medicine, Division of Infectious Diseases and Jennie Kwon, DO, MSCI, Washington University School of Medicine

Presentations:
10:30 AM
972
Asymptomatic Carriage of Clostridiodes difficile and Risk of Subsequent Infection
Katrina Espiritu, MPH; Michael Vernon, DrPH; Donna Schora, MT(ASCP); Lance Peterson, MD; Kamaljit Singh, MD
10:45 AM
973
Inter-facility patient sharing and Clostridium difficile incidence in the Ontario hospital network: a 13-year longitudinal cohort study of 116 hospitals
Kevin Brown, PhD; Nick Daneman, MD, MSc; Kevin Schwartz, MD, MSc; Bradley Langford, BScPhm ACPR PharmD BCPS; Jennie Johnstone, MD, PhD; Kwaku Adomako, MSc; Jacob Etches, PhD; Gary Garber, MD, FACP, FIDSA
11:00 AM
974
Impact of Mandatory Infectious Disease (ID) Specialist Approval on Hospital-Onset Clostridium difficile (HO-CDI) Testing and Infection Rates: Results of a Pilot Study
Michael Y. Lin, MD, MPH; Tiffany Wiksten, RN, CIC; Alexander Tomich, DNP, RN, CIC; Mary K. Hayden, MD, FIDSA, FSHEA; John Segreti, MD, FIDSA, FSHEA
11:15 AM
975
Clostridium difficile Infection and Antibiotic Prescription Rates in the Community: Explaining the Gender Gap
Mariam Younas, MD; Julie Royer, MPH; Hana Rac, PharmD; Julie Ann Justo, PharmD, MS; P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCPS, AAHIVP; Sharon Weissman, MD; Anton Maki Jr., M.D., MBA, FRCPC, FCAP, FACP; Linda Bell, MD; Katie Stilwell Waites, MPH; Sangita Dash, MD; Majdi N. Al-Hasan, MBBS
11:30 AM
976
Clostridium difficile colonization molecular epidemiology and anti-toxin serological responses in healthy infants: A prospective cohort study
Larry Kociolek, MD, MSCI; Ciaran P. Kelly, MD; Robyn Espinosa, MPH; Maria Budz, MT; Aakash Balaji, BS; Egon Ozer, MD, PhD; Robert Tanz, MD; Xinhua Chen, PhD; Dale N Gerding, MD, FIDSA

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.